Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration.

[1]  R. D. Da Riol,et al.  Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. , 1992, The Journal of pediatrics.

[2]  K. Shannon,et al.  Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study. , 1992, The Journal of pediatrics.

[3]  R. Ohls,et al.  Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. , 1991, The Journal of pediatrics.

[4]  I. Macdougall,et al.  Clinical Pharmacokinetics of Epoetin (Recombinant Human Erythropoietin) , 1991, Clinical pharmacokinetics.

[5]  I. L. Smith,et al.  Age-Related Differences in Erythropoietic Response to Recombinant Human Erythropoietin: Comparison in Adult and Infant Rhesus Monkeys , 1990, Pediatric Research.

[6]  Adesh K. Jain,et al.  Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. , 1990, Blood.

[7]  J. Widness,et al.  42 DEVELOPMENTAL CHANGES IN ERYTHROPOIETIN (Ep) PHARMACOKINETICS IN FETAL AND NEONATAL SHEEP , 1990, Pediatric Research.

[8]  P. Scigalla,et al.  Erythropoietin: From Molecular Structure to Clinical Application , 1990 .

[9]  Vlasses Ph,et al.  Epoetin: human recombinant erythropoietin. , 1989 .

[10]  R. Degowin,et al.  Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial. , 1989, Annals of internal medicine.

[11]  J. Brockmöller,et al.  Pharmacokinetics of recombinant human erythropoietin after SC administration and in long-term IV treatment in patients on maintenance hemodialysis. , 1989, Contributions to nephrology.